AsiaPCR2014 Programme Final

16th-18th January, 2014 - Singapore

15th January, 2014 - Practical PCI Pre-Course

The Course programme

Faculty interviews

Abstract posters

Exhibit guide

Words from the industry partners

and more...

Programme

AsiaPCR/SingLIVE 2014 - Programme2

Welcome home!

AsiaPCR/SingLIVE 2014 is the first of the

PCR family Courses of the Year. This Course

has established itself as a unique forum for

expression of the interventional community,

hosted by our colleagues from Asia-Paci c region. The impact of

research, innovation and clinical expertise from the region has

become essential to the progress of interventional medicine

worldwide. At the same time, the Course recognises speci c

needs and demands of participants to AsiaPCR/SingLIVE. This

is re ected in this years programme, with some new features,

sessions that are unique to Asia, and a growing emphasis on

interactive Learning sessions. The educational experience will

start with another edition of the successful Practical PCI Pre-

Course, focusing on practical aspects of coronary intervention,

as relevant to the region at large.

The PCR community needs your input and evaluation in order to

continuously improve AsiaPCR/SingLIVE and other PCR Courses

alike. Please pay careful attention to the LIVE demonstrations.

The broadcasting teams and session chairs have worked hard

to try and improve on their educational content. We aim at

maximising the added value for your practice and at increasing

your interaction, either during or after case completion, such

that any question you may have shall be addressed.

New this year, you are all invited to join an informal lunch

discussion on Saturday 18th January from 12:00 in the exhibition

area. This will be a unique opportunity to share your feedback,

to raise yet unanswered questions or to provide suggestions

to Course Directors and Programme Committee Members,

highlighting what went well, and what can be further improved.

Enjoy the exchange of knowledge and experience: we have so

much to learn from each other, all for the bene t of patient care

and well being!

William Wijns

Chairman of PCR

EDITORIAL

EditorialDear Friends,

We offer a warm

welcome to all of you

attending AsiaPCR/

SingLIVE 2014, our 5th

session of this increasingly dynamic world-class Course. With

the experience of our Asian and international colleagues, the

dedication of our Faculty and Programme Committee Members

and the incredible resources of the PCR Family we are proud to

present a Course that is designed By & For you, offering the very

best in practical information and education.

For those who participated in the Practical PCI Course that took

place the day before AsiaPCR/SingLIVE 2014 began, you already

have an idea of what to expect during the next few days that we

will spend together.

The 2014 programme will continue to highlight new stent

developments and techniques. We will share the expertise

of specialists from India, China and Thailand, through LIVE

transmissions in the state-of-the-art treatment of left main,

CTOs, bifurcations and transradial procedures.

We are especially excited about new aspects of this years

programme that include the increasing collaboration between

regional PCI communities, encouraging the active cross

border exchange of knowledge and learning. There will be

sessions showcasing complications from 5 different countries;

individual programme segments emphasising structural heart

interventions using MitraClip, TAVI and LAA; ongoing discussions

between world experts on the latest developments in renal

denervation; and a totally new track created by PCR Familys

renown Educative Solutions Research Group offering fresh

perspectives and new levels of interactivity to the Course.

We cordially invite you to our very special Lunch with the Course

Directors. A unique platform for the exchange of practical

pointers, allowing for the direct and informal interaction

between Course Directors and participants.

Tian-Hai Koh Eric Eeckhout

Course Director Course Director

3AsiaPCR/SingLIVE 2014 - Programme

BOARD MEMBERS

Course Directors

Course Co-Directors

Tian Hai Koh SINGAPORE

Eric Eeckhout SWITZERLAND

Jean FajadetFRANCE

Christoph K. NaberGERMANY

Junbo GeCHINA

Shigeru SaitoJAPAN

Soo Teik LimSINGAPORE

Patrick W. SerruysTHE NETHERLANDS

Marie-Claude MoriceFRANCE

Aaron Wong SINGAPORE

Takashi Akasaka, JAPAN

Siro Buendia, SPAIN

Praveen Chandra, INDIA

Jun-Jack Cheng, TAIWAN

Paul Chiam, SINGAPORE

Chee-Tang Chin, SINGAPORE

Giulio Guagliumi, ITALIA

Kentaro Hayashida, JAPAN

Myeong-Ki Hong, SOUTH KOREA

Veronica Kwok, SINGAPORE

Michael Lee, HONG KONG

Felix Mahfoud, GERMANY

Hung Pham Manh, VIET NAM

Sundeep Mishra, INDIA

Rosil Mohd Ali, MALAYSIA

Ngoc Quang Nguyen, VIET NAM

Marko Noc, SLOVENIA

Siddhart Radhakrishnan, INDIA

Sharad Shetty, AUSTRALIA

Sunarya Soerianata, INDONESIA

Satoru Sumitsuji, VIET NAM

Jack Tan, SINGAPORE

Ju Le Tan, SINGAPORE

Wasan Udayachalerm, THAILAND

Wan Ahmad Wan Azman, MALAYSIA

Chiung-Jen Wu, TAIWAN

Khung Keong Yeo, SINGAPORE

Robaayah Zambahari, MALAYSIA

Bin Zhang, CHINA

Programme Committee Members

Directors & Co-Directors


GUEST FACULTY

Aaron Wong, SINGAPORE

Abdul Wahab Bin Undok, MALAYSIA

Achmad Fauzi Yahya, INDONESIA

Adrian Low, SINGAPORE

Afzalur Rahman, BANGLADESH

Ajit Menon, INDIA

Aman Salwan, INDIA

Andrew Ong, AUSTRALIA

Ani Yearoo, MAURITIUS

Antonia Anna Lukito, INDONESIA

Arthur Tan, SINGAPORE

Asha Mahilmaran, INDIA

Ashok Seth, INDIA

Ashwin Mehta, INDIA

Benjamin Chua, SINGAPORE

Bernard Chevalier, FRANCE

Bin Zhang, CHINA

Brian Khoo, SINGAPORE

Bruno Farah, FRANCE

Bruno Garcia Del Blanco, SPAIN

Budi Baktijasa Darmadjati, INDONESIA

Burdi Yuli Setianto, INDONESIA

Carlo Briguori, ITALY

Chee Tang Chin, SINGAPORE

Cheng-I Cheng, TAIWAN

Chi Hung Huang, TAIWAN

Chia-Yu Chou, TAIWAN

Chiang Soo Tan, MALAYSIA

Chih-Kuan Liao, TAIWAN

Chinniah Saraswathy, SINGAPORE

Chiung-Jen Wu, TAIWAN

Chong-Hiok Tan, SINGAPORE

Choong Meng Chan, SINGAPORE

Chris Kwok Yiu Wong, HONG KONG

Christoph K. Naber, GERMANY

Chun-Ming Shih, TAIWAN

Damras Tresukosol, THAILAND

David Wong, USA

Debasis Ghosh, INDIA

Debdatta Bhattacharya, INDIA

Derek Yong, SINGAPORE

Dick Chi Yeung Cheung, HONG KONG

Didier Tchtch, FRANCE

Dinh D Huy, VIET NAM

Doni Firman, INDONESIA

Eberhard Grube, GERMANY

Eric Eeckhout, SWITZERLAND

Eric Chi Yuen Wong, HONG KONG

Etsuo Tsuchikane, JAPAN

Evgeniy Merkulov, RUSSIAN FEDERATION

Fabio Enrique Posas, PHILIPPINES

Fahim H Jafary, SINGAPORE

Faizal Ali, INDIA

Fazila Malik, BANGLADESH

Felix Mahfoud, GERMANY

Feng-Yu Kuo, TAIWAN

Fuminobu Yoshimachi, JAPAN

G. Sengottuvelu, INDIA

Gary Cheung, HONG KONG

Gerald Yong, AUSTRALIA

Gim-Hooi Choo, MALAYSIA

Giulio Guagliumi, ITALY

Giuseppe De Luca, ITALY

Gokul Reddy Mandala, INDIA

Hana Trisnohadi, INDONESIA

Harry Suryapranata, THE NETHERLANDS

Hee Hwa Ho, SINGAPORE

Ho Thuong Dung, VIET NAM

Hsiu Yu Fang, TAIWAN

Huay Cheem Tan, SINGAPORE

Hyeon-Cheol Gwon, SOUTH KOREA

Ib Vijayalakshmi, INDIA

In-Ho Chae, SOUTH KOREA

Jack Tan, SINGAPORE

Jacques Berland, FRANCE

Jacques Monsegu, FRANCE

Jagdish S Hiremath, INDIA

James Yip, SINGAPORE

Jason Loh, SINGAPORE

Jaspal Arneja, INDIA

Jean Fajadet, FRANCE

Jia Lin Soon, SINGAPORE

Jiang Ming Fam, SINGAPORE

Joo-Yong Han, SOUTH KOREA

Jose Maria De La Torre Hernandez, SPAIN

Ju Le Tan, SINGAPORE

Juan F. Iglesias, SWITZERLAND

Julian Ko-Beng Tan, SINGAPORE

Jun-Jack Cheng, TAIWAN

Junbo Ge, CHINA

Junko Honye, JAPAN

Kam-Tim Chan, HONG KONG

Kang Cheng, CHINA

Kay-Woon Ho, SINGAPORE

Keith G. Oldroyd, UNITED KINGDOM

Kentaro Hayashida, JAPAN

Kevin Yau Tung Wai, HONG KONG

Khang-Leng Leow, SINGAPORE

Khe-Sui, James Ho, PHILIPPINES

Khung Keong Yeo, SINGAPORE

Kiang Hiong Tay, SINGAPORE

Kok Han Chee, MALAYSIA

Kui-Hian Sim, MALAYSIA

Kyo Eisho, JAPAN

Lam Ho, HONG KONG

Latchumanadhas Kalidoss, INDIA

Lee Yian Ping, SINGAPORE

Leslie Lam, SINGAPORE

Leslie Tay, SINGAPORE

Limpijankit Thosaphol, THAILAND

Linda Lison, INDONESIA

Lip Ping Low, SINGAPORE

Luc Bilodeau, CANADA

M Nasir Muda, MALAYSIA

Man Hong Jim, HONG KONG

Manh-Hung Pham, VIET NAM

Manish Taneja, SINGAPORE

Manoj Kumar, INDIA

Marc Bedossa, FRANCE

Marie-Claude Morice, FRANCE

Mark Chan, SINGAPORE

Mark Rosenberg, GERMANY

Marko Noc, SLOVENIA

Martyn Thomas, UNITED KINGDOM

Masahiko Ochiai, JAPAN

Masato Nakamura, JAPAN

Mathew Samuel Kalarickal, INDIA

Maurice Choo, SINGAPORE

Maurizio DAmico, ITALY

Our sincere thanks to the Guest Faculty


GUEST FACULTY

Mazeni Alwi, MALAYSIA

Michael Lim, SINGAPORE

Michael Nguyen, AUSTRALIA

Michael Kang-Yin Lee, HONG KONG

Muhammad Munawar, INDONESIA

Muhammad Yamin, INDONESIA

Myeong-Ki Hong, SOUTH KOREA

N. N. Khanna, INDIA

Nagendra Chouhan, INDIA

Nakrai Nutcharee, THAILAND

Naoto Inoue, JAPAN

Nazir Ahmed, BANGLADESH

Ngoc-Quang Nguyen, VIET NAM

Nicolas Foin, SINGAPORE

Nwe Nwe, MYANMAR

Olivier Varenne, FRANCE

Oteh Maskon, MALAYSIA

Partha Sarathi Banerjere, INDIA

Patrick W. Serruys, THE NETHERLANDS

Paul Chiam, SINGAPORE

Paul Jau Lueng Ong, SINGAPORE

Peter Yan, SINGAPORE

Philip Koh, SINGAPORE

Philip Wong, SINGAPORE

Pintoko Tedjokusumo , INDONESIA

Po-Ming Ku, TAIWAN

Prakas Chandra Mondal, INDIA

Praveen Chandra, INDIA

Praveer Agarwal, INDIA

Pravin Kumar Goel, INDIA

Quang Huan Do, VIET NAM

Quang-Tuan Nguyen, VIET NAM

Rabindra Nath Chakraborty, INDIA

Rajeeve Kumar, INDIA

Rajpal K Abhaichand, INDIA

Ravinay Bhindi, AUSTRALIA

Reginald Low, USA

Richard Ng, SINGAPORE

Robaayah Zambahari, MALAYSIA

Robert-Jan Van Geuns, THE NETHERLANDS

Rogelio Tangco, PHILIPPINES

Ronald Chi-Hang Lee, SINGAPORE

Rosil Mohd Ali, MALAYSIA

Sajidah Khan, SOUTH AFRICA

Satoru Sumitsuji, JAPAN

Scott Harding, NEW ZEALAND

See-Hooi Ewe, SINGAPORE

Selvanayagi Sundrasenan, MALAYSIA

Seung-Ho Hur, SOUTH KOREA

Seung-Jung Park, SOUTH KOREA

Seung-Woon Rha, SOUTH KOREA

Shao-Liang Chen, CHINA

Sharad V Shetty, AUSTRALIA

Shigeru Saito, JAPAN

Shozo Ishihara, JAPAN

Simon Redwood, UNITED KINGDOM

Siro Buendia, SPAIN

Sitaraman Radhakrishnan, INDIA

Sivakumar Rathnavel, INDIA

Sodiqur Rifqi, INDONESIA

Soe-Win Kyaw, MYANMAR

Sok Chour, CAMBODIA

Soo Teik Lim, SINGAPORE

Sreenivas Kumar Arramraju, INDIA

Stefan Hardt, GERMANY

Stephane Cook, SWITZERLAND

Stephen Lee, HONG KONG

Subhash Chandra, INDIA

Sudipt Chakraborty, HONG KONG

Sunao Nakamura, JAPAN

Sunarya Soerianata, INDONESIA

Sundeep Mishra, INDIA

Sung Yun Lee, SOUTH KOREA

Suphot Srimahachota, THAILAND

Surya Prakasa Rao Vithala, INDIA

Swee-Choon Ng, MALAYSIA

Tae-Jin Youn, SOUTH KOREA

Takashi Akasaka, JAPAN

Takehiro Yamashita, JAPAN

Tamil Selvan, MALAYSIA

Tapan Ghose, INDIA

Teguh Santoso, INDONESIA

Than Than Kyaing, MYANMAR

Thanawat Benjanuwattra, THAILAND

Thanh Nhan Vo , VIET NAM

Thomas Cuisset, FRANCE

Thuong Nghia Nguyen, VIET NAM

Tian-Hai Koh, SINGAPORE

Tien-Ping Tsao, TAIWAN

Tina Teo, SINGAPORE

Tiong Kiam Ong, MALAYSIA

Tom Slagboom, THE NETHERLANDS

Toon Wei Lim, SINGAPORE

Toshiya Muramatsu, JAPAN

Upendra Kaul, INDIA

Veronica Kwok, SINGAPORE

Victor Chao, SINGAPORE

Viveka Kumar, INDIA

Wacin Buddhari, THAILAND

Wah Hak Nien Shen, Charles Chan, SINGAPORE

Wan Ahmad Wan Azman, MALAYSIA

Wasan Udayachalerm, THAILAND

Wen-Yi Guo, CHINA

Wijeyasingam Santharaj, SRI LANKA

William Hau, HONG KONG

William Wijns, BELGIUM

Wirash Kehasukcharoen, THAILAND

Woo-Young Chung, SOUTH KOREA

Ya-Ling Han, CHINA

Yean-Teng Lim, SINGAPORE

Yong Huo, CHINA

Yong Hoon Kim, SOUTH KOREA

Yoong-Kong, Kenny Sin, SINGAPORE

Yu-Lin Ko, TAIWAN

Yudi Her Oktaviono, INDONESIA

Yuji Hamazaki, JAPAN

Zee-Pin Ding, SINGAPORE


The number of interventional procedures continues to rise in

most Asian countries, powered by China and India, but also in

the ASEAN countries. New cardiac catheterisation laboratories

are constantly being set up across the region, and there is an

ongoing need for the training of young interventional cardio-

logists that are needed to sta them.

This year, AsiaPCR-SingLIVE Course celebrates its fth edition. The

meeting has grown in the number of participants, content and

submissions of scienti c abstracts and clinical cases. The AsiaPCR/

SingLIVE meeting hence serves to highlight the latest international

practices and recommended PCI guidelines from the West, with

input by key opinion leaders from Asia. This is critical as practices

and expertise vary across di erent regions in Asia. Equally, cultural

preferences and genetic make-up of the people in Asia can also vary

from the West. Major Asian centres are also embarking on structural

heart interventions, and Asian registries of such device based inter-

ventions should be helpful in identifying any di erences compared

to the Western experience.

It is with this in mind that the special issue AsiaIntervention, a new

publication dedicated to the cardiovascular interventional eld

within the Paci c Rim region, has been created. The aim of the cur-

rent issue is to highlight the endeavours of APSIC, ASPC and the

Chien Foundation in developing further scienti c progress within

the broad international region. The issues contents are linked also to

AsiaPCR/SingLIVE 2014, by publishing the accepted oral abstracts of

the meeting including a small selection of the best papers and invit-

ing the participating National Societies at AsiaPCR/SingLIVE 2014 to

present their organisations.

We hope you enjoy reading AsiaIntervention and look forward to

seeing you here during AsiaPCR/SingLIVE 2014.

Guest Editors Editor-in-Chief

A/Prof. Tian-Hai Koh Prof. Patrick W. Serruys

Prof. Eric Eeckhout

AsiaIntervention, a dedicated regional issue

Interactive Case Corner!

You are invited to actively participate in the

Interactive Case Corner, a place of communication,

free from any pressure. Selected presenters

will share their most educational cases and the

facilitators listed below will stimulate interactivity.

Thursday 16th January

10:30-12:00 - R.K. Abhaichand, B. Chevalier

14:00-14:40 - J. Fajadet, G. Sengottuvelu

14:45-16:00 - J.B. Ge, M.C. Morice

16:15-17:30 - N. Chouhan, W.A. Wan Azman, W. Wijns

Friday 17th January

09:00-10:30 - S. Khan, S. Nakamura

10:45-12:00 - R.N. Chakraborty, S. Khan, S. Nakamura

14:00-14:40 - N. Chouhan, R.l. Low, R. Zambahari

14:45-16:00 - R.I. Low, T. Selvan

16:15-17:30 - B. Chua, N. Khanna, K.K. Yeo

Saturday 18th January

08:30-09:30 - S. Khan, S.C. Ng

09:35-10:35 - S. Khan, S.C. Ng

10:45-11:45 - R.M. Ali, P. Chiam, K. Hayashida


CHIEN FOUNDATION

The Chien Foundation is a charitable foundation set up in Singapore

17 years ago, in January 1997, by philanthropist Mr. Teddy Chien and

Dr. Richard Ng. It is for the purpose of promoting education, training

and research in cardiovascular medicine, focusing on interventional

cardiology. The aim is to bene t young cardiology doctors in the Asian

Paci c region to be trained in fellowship programs in more advanced

cardiac centers. Six years ago, the Foundation expanded its programs

to include Best Abstract presentations for young investigators in Asia-

Paci c PCI meetings such as CIT in Beijing/Shanghai China, TCTAP

meeting in South Korea and the AsiaPCR-SingLive meeting here.

The Chien Foundation has also awarded Chien Foundation Lectureship

to honour outstanding teachers, mentors and promoters in education

& research in PCI in Asia, Europe, U.S.A. and internationally. So far, the

recipients have included Profs./Drs. Eberhard Grube, Alan Yeung, Jean

Marco, Patrick W. Serruys, Seung-Jung Park, Harry Suryapranata, Gao

Runlin, Martin Leon, Robaayah Zambahari, Richard Ng, Tian-Hai Koh,

Jean Fajadet and Shigeru Saito.

This year, the Chien Foundation Board of Trustees together with Prof.

Tian-Hai Koh of AsiaPCR/SingLIVE 2014 and the National Heart Centre

Singapore, have nominated Dr. Marie-Claude Morice from France. She

has been a great champion in her lifelong dedication to the practice,

promotion and teaching of high standards of PCI.

Dr Morices CV is very impressive and we wish to highlight some of it here:

Dr Morice graduated from University of Paris VII in 1973 and immediately

specialised in cardiology. She started her PCI training with Prof Jean

Marco in Toulouse in 1984 and in 1986 was promoted to be Head of PCI

or PTCA in Centre Cardiologique du Nord in Paris.

In 1995, she was further promoted to be Head of Institute Cardiovascular

Paris Sud and co-founded the French study group on Coronary Stenting

without Coumadin, and the Indo-French Foundation of Interventional

Cardiology.

She has participated in all major interventional LIVE meetings in America,

Europe, South America, Asia, and has been a lucid and outstanding

lecturer and teacher at the Singapore LIVE PCI courses over the many

years since inception.

Dr. Morice has been active to advance research programs in PCI.

Amongst her many research activities are principal investigators of

RAVEL, the rst randomised trial on DES; Principal investigator of the

Reality study and Co-Principal investigator of the Syntax study.

In her current position as Advisor of EuroPCR, she is a very instrumental

promoter of joint PCR Courses.

Dr. Richard Ng

Co-Founder & Senior Trustee

Chien Foundation

^ ABBOTT VASCULAR

^ ALVIMEDICA MEDICAL TECHNOLOGIES

^ ASAHI INTECC CO., LTD

^ B.BRAUN SINGAPORE PTE LTD

^ BALTON

^ BIOSENSORS INTERNATIONAL

TECHNOLOGIES PTE LTD

^ BIOTRONIK

^ BOSTON SCIENTIFIC ASIA PACIFIC PTE

LTD

^ CENTER FOR EUROPEAN RESEARCH IN

CARDIOVASCULAR MEDICINE

^ COVIDIEN

^ EDWARDS LIFESCIENCES

^ GOODMAN CO., LTD

^ HEXACATH SAS

^ INNOHEART

^ KANEKA MEDIX CORPORATION

^ MAQUET SOUTH EAST ASIA PTE LTD

^ MEDTRONIC INTERNATIONAL LTD

^ MINVASYS

^ ORBUSNEICH

^ P.G BOOKS PTE LTD

^ RESEARCHBOOKS ASIA PTE LTD

^ ST JUDE MEDICAL

^ STENTYS

^ TERUMO ASIA HOLDINGS PTE.LTD

^ TRANSMEDIC

Thanks to our partners!

Designations used by companies to distinguish their products are often claimed as trademarks. Brand names and product names used in this Programme may be trade names, service marks, trademarks or registered trademarks of their respective owners.

Marie-Claude Morice

Chien Foundation award for outstanding lectureship& lifetime achievement in PCI

AsiaPCR/SingLIVE collaborates with the following organisations:

CARDIOVASCULAR SUMMIT-TCTAP 2014 and NHCS

?

!

Post instant messages to the chairpersons via your smartphone!

Any questions or comments for the speakers, panellists or operators?

Dont be shy, these anonymous contributions will feed the debate on stage!

React@PCR

NEW!

Available in Main Arena

Connect to www.reactatpcr.com. Free wi accessible at level 3 and 4.

Select the network FREE_WIFI@SuntecSingapore. No password required.


INTERVIEW

An interview with... Achmad Fauzi Yahya

The Indonesian perspective on managing complications of

percutaneous coronary procedures

Achmad Fauzi YahyaHasan Sadikin hospital, Bandung, Indonesia

Achmad Fauzi Yahya, Hasan Sadikin hospital, Bandung,

Indonesia explains why adequate preparation is the key to

reducing the risk of complications in patients undergoing

coronary interventions. He also reviews the steps that the

Indonesia government is taking to ensure all patients in

Indonesia receive a high-quality service.

g Is there universal provision of care for people requiring

coronary interventions in Indonesia? For example, do some

people living in remote areas have poor access to care?

Indonesiaand almost all other countries around the world

have major issues in providing access to healthcare for people

living in rural and remote areas. In terms of cardiovascular

intervention, the challenge is to ensure that all areas of

Indonesia receive a high-quality service.

g What steps are being taken to improve provision of care

in Indonesia?

The Indonesian government is just starting to implement a

universal healthcare system, which will cover all Indonesian

citizens by 2019. It will take five years to roll out completely,

but the idea is that eventually everyone will have access to

healthcare that is free at the point of use. The new scheme will

cover almost all services, including cardiovascular interventions.

Also, the government is working intensely with the private

sector and professional bodies such as the Indonesian Society

of Interventional Cardiology to overcome the countrys current

problems of a shortage of interventional cardiologists and

limited cath lab facilities. Therefore, in recent years, the numbers

of cath labs have increased in both public and private hospitals.

Furthermore, hospitals (private or public) are encouraged to

meet certain standard of care if they are to become a centre

of interventional cardiology training. We co-operate with

neighbouring countries in Asia, and those in Australia and

Europe to ensure our interventional cardiology fellows receive

the appropriate training.

g What are the key risk factors for coronary complications

(eg. age, comorbidities) in Indonesia?

There are no difference in terms of the key risk factors for

coronary complications between the Indonesia population

and those of other countries. The risk factors can include

comorbiditiesfor example, diabetes, chronic kidney disease,

stroke, or left ventricular dysfunctionbut complex lesions

(ie. heavy calcification, tortuosity, bifurcation and proximal

or ostial lesions) are also notorious for increasing the risk of

complications. Modifiable risk factors include operator

experience and poorly prepared facilities. At the moment, we

are trying to conduct a registry of complications that occur

during percutaneous coronary intervention in Indonesian

centres across the country.

g In Indonesia, in your experience, what are the most

common coronary complications?

From my perspectivealthough complications are quiet

rare nowadaysthe slow/no reflow is the most common

complication encountered followed by perforations and

trapped devices.

g What steps can be taken to prevent these complications?

Rigorous preventive measures can reduce the risk of

complications. Therefore, it is important to have a fully

equipped cath lab. As operators, we have to sharpen our skills

and improve our knowledge so that we can truly see the face of

our hidden enemy (ie. the complexity of the lesion). We should

not forget to adequately prepare the lesion before putting in

the stentit is better not to get into trouble in the first place

than to try to get out of trouble!

g If one of these complications occurs, how should they be

managed?

If there is a complication, do not ignore it! Some can be

managed by simple techniques. But if we do not know how to

overcome a complication or we fail to overcome a complication,

we should not hesitate to ask for help from other colleagues.

g Can you give an example of when you had a complication

during a coronary procedure and how you managed it?

If I had a coronary perforation, I would perform prolonged

inflation at low pressure (46atm for 10 minutes). The covered

stent will help if the balloon inflation has failed. Coil material

is another tool in our armamentarium to stop the perforation

at the distal end of an artery. If sealing is unsuccessful, then

reversing the anticoagulation with protamine can work. A

few patients need pericardiocentesis. However, we do not do

injection of thrombin, gelatin sponge or polyvinyl form to seal

the perforation.

g What advice would you give to a young interventional

cardiologist regarding the preparations they need to

make to avoid complications during a procedure?

They need to be aware that potentially fatal complications

can occur if the operator does not take the time to sit and

think about the steps they need to take before undertaking

a procedure. Also, they should not rush to do an ad-hoc PCI

procedure for complex casesit is important to take the time

to evaluate the vessel anatomy and lesions character before

deciding the strategy. Also, they should remember to learn from

other peoples mistakes!

An interview with... Andrew Ong

Cardiac catheterisation in practice

Andrew Ong Westmead Hospital, Westmead, Australia

Andrew Ong (Westmead Hospital, Westmead, Australia)

provides practical tips for choosing the right catheter for a

coronary catheterisation procedure. He also describes the

benefits of the radial approach vs. the femoral approach

and advises on how to manage complications.

g What are the key considerations when choosing a

catheter for a cardiac catheterisation procedure?

The chosen catheter must be the correct shape to fit the

patients anatomy, and also must be the correct size the size

will depend on whether the patient is undergoing a diagnostic

or interventional procedure. Furthermore, a catheter must

adequately opacify the vessel studied and it must provide

enough support for the equipment to be used to treat the

vessel.

g If the results of the angiogram are not clear, would you

use an additional diagnostic procedure such as fractional

flow reserve (FFR)?

If, after diagnostic coronary angiography, there is a question

regarding the severity of the lesion and the patient has not

undergone a functional test prior to the procedure, then a

functional test such as FFR can help to determine whether the

lesion requires intervention. Also if there is doubt regarding

the anatomical make-up of the lesion, or assessing vessel

calcification, then imaging with intravascular ultrasound (IVUS)

may be helpful.

g When would you use the radial approach and when

would you use the femoral approach for a percutaneous

coronary intervention (PCI) procedure?

The radial approach is my default approach because the

complication rate is clearly lower with the radial approach and

it is also far more comfortable for the patient. But I would use

the femoral approach when there are no radial pulses, if I have

to use an 8-French guide catheters (7-French in those with tiny

radial arteries), or if I have to insert an intra-aortic balloon pump.

g If choosing the transfemoral approach, what steps would

you take to reduce the risk of bleeding?

The main cause of life-threatening bleeding with the

transfemoral approach is a high puncture above the inguinal

ligament, which means there is no femoral head to provide

counter pressure during manual compression. It is therefore

mandatory to check the position of the inguinal ligament

relative to the skin or arterial puncture site prior to starting the

procedure. I also use a micropuncture kit when the anatomy

is tricky or when there is a need to ensure a single puncture.

In recent years, some operators have started to routinely use

ultrasound to localise their puncture site; however, I find that

ultrasound distracts from the procedure.

g If choosing the transradial approach, what steps would

you take to reduce the risk of radial spasm?

Radial artery spasm occurs in 30% of patients. Therefore, I

do not routinely use vasodilators [to reduce the risk of radial

spasm] as 70% of patients will not have a problem. But for

selected patients (eg. young or those with small radial arteries),

I use a combination of intra-arterial verapamil and nitroglycerin

injected via the radial sheath. I do routinely lightly sedate

patients with midazolam and fentanyl to relax them, and that

reduces the risk of radial spasm.

g If bleeding occurs, how should it be managed?

Bleeding is an important complication and must be addressed

quickly. Firstly, one must assess the patient to ensure that

they are haemodynamically stable; if they are not, one should

institute resuscitation procedures to stabilise them. At the same

time, the site of bleeding must be identified, and imaging, with

a view to an intervention, may need to be performed if local

control of the bleeding cannot be achieved.

g Aside from bleeding, what other complications can occur

during cardiac catheterisation procedures and how can

they be prevented?

The other major complications, apart from bleeding, that are

important are arterial dissection, and stroke. Arterial dissection

can be prevented by gently manipulating the equipment

through the arterial tree and feeling for any resistance along

the way. It is always important to screen the equipment using

X-ray guidance when there is any doubt as to how things are

progressing. To prevent stroke, it is important to minimise

unnecessary manipulation in the arterial tree, to be concise

and accurate in the conduct of the cardiac catheterisation

procedure.

g What are your tips for guiding a catheter through

tortuous anatomy?

As mentioned above, X-ray guidance is paramount in ensuring

that the equipment passes through the arterial tree smoothly.

With tortuous anatomy, the use of additional equipment such

as a hydrophilic guidewire is useful, as well as the use of a

long flexible sheath to protect the catheters from the tortuous

anatomy during catheter exchanges. It is important to flush

the catheter in cases of tortuosity in case the tip has picked up

plaque along the way.

INTERVIEW


INTERVIEW

An interview with... Sunao Nakamura

Choosing the right wire for the job

Sunao NakamuraNew Tokyo Hospital, Chiba, Japan

Sunao Nakamura, New Tokyo Hospital, Chiba, Japan,

outlines the factors that go into choosing the correct

guidewire for a coronary catheterisation procedure and

discusses the complications that can occur if the wrong

wire is chosen.

g How does the lesion type influence your choice of wire?

With chronic total occlusions, my choice for the first wire is the

Fielder FC as a chronic total occlusion lesion is not always hard

and the stiffness of the wire is sufficient to cross the lesion.

If the lesion is too hard for the Fielder FC wire, it should be

exchanged for a stiffer wire; however before changing the wire,

the Corsair microcatheter can be advanced with Fielder FC and

also it can explore available channels without causing any injury.

g Regardless of the approach used, what are the main factors

to consider when choosing a wire for a catheterisation

procedure?

The trackability to any kind of tortuous vessel is the most

important characteristic of the wire. For example with the

retrograde approach, the channels are often meandering or

corkscrewunless the wire smoothly tracks such winding,

the channels will be damaged. Therefore, the wire should be

flexible enough to track the vessel anatomy.

g What are the potential barriers to choosing the best wire

for the job?

Both cost and lack of availability are barriers in this respect.

g What complications can occur if a wire is incorrectly

chosen?

An incorrectly chosen wire with the retrograde approach may

cause damage to the channel, which may lead to coronary

perforation. With the antegrade approach, a wire that is harder

than necessary may get into and widen subintima space. If this

happens, then a large haematoma could form and compress

the collateral channels to cause myocardial ischemia.

g What are the latest data for the best retrograde and

antegrade wiring techniques?

The best techniques have been thoroughly discussed, and

we [as interventional cardiologists] have exchanged our

experiences with each other at many international conferences.

Therefore while there are not any official guidelines for the best

techniques, leading interventionist have reached consensus

about what these techniques are.

g When planning a procedure that involves crossing

coronary collaterals, what is the most import factor to

consider?

The most important factor is to preserve collaterals without

causing damage.

g What are the optimal characteristics for a wire that will be

required to cross collaterals?

Trackability of the wire is the most important factor. However,

this needs to be achieved without sacrificing flexibility and

litheness so that you do not cause damage to the collaterals.

Newly developed devicessuch as the Sion guidewire series

enable us to track vessels without losing smooth and lithe

movement.

g What are the challenges of crossing collaterals and how

can they be overcome?

In the past, the retrograde approach for crossing collaterals

was a challenging technique but it has evolved over the past

decade. Many good wires and catheters, such as the Corsair

microcatheter, have now been developed to overcome these

types of challenging anatomy. Therefore, I would say that

crossing collaterals is a reasonable challenge but it is not as

great a challenge as it used to be.

g Do you have any tips or tricks for crossing collaterals?

When wire goes into subintima space, it may compress

collaterals and this can lead to damage. Therefore, this should

be definitely avoided. You need to have a have a good

understanding of anatomy of coronary arteries. You should pay

the best attention when you advance a wire, which should be

done carefully, cautiously and prudently. Be prepared for any

possible scenario that you can think of.



INTERVIEW

An interview with... Bin Zhang

Using PCI to manage chronic total occlusions

Bin ZhangGuangdong Provincial Cardiovascular Institute Guangzhou, China

Coronary artery bypass grafting (CABG) is often the

preferred revascularisation strategy for managing patients

with chronic total occlusions (CTOs) because percutaneous

coronary intervention (PCI) can be complicated and is

associated with lower rates of revascularisation. However,

PCI in this group of patients can beneficial (eg. for improved

left ventricular function). Bin Zhang (Guangdong Provincial

Cardiovascular Institute Guangzhou, China) reviews the

use of PCI in patients with CTOs.

g When a patient presents with a chronic total occlusion

and is deemed eligible for revascularisation, how do you

decide between PCI and CABG?

When deciding between CABG and PCI, you need to consider

what will provide the best long-term outcome. Patients who

are being considered for PCI must have appropriate clinical

indication and suitable anatomy. Appropriate clinical indications

for PCI management of CTOs include persistent angina and

demonstration of large reversible ischaemia on non-invasive

imaging. The choice of using PCI or CABG to manage a CTO not

only depends on what guidelines recommend and evidence

from randomised trials, but also depends on the heart team, the

interventionists skills and surgeons experience. If you are going

to perform PCI in a patient with a complex lesion such as a CTO

or a difficult bifurcation, then you must have the appropriate

expertise.

g What are the benefits of using PCI to manage CTOs?

We do not have a large randomised controlled trial that

compares contemporary PCI vs. optimal medical therapy for

the management of CTOs. However, based on our centres

experience, we do know PCI for CTO is more effective in

reducing residual ischaemia and controlling symptoms of

angina than optimal medical therapy alone. In my practice, most

CTOs are managed with PCI rather than CABG. This is because

most of my patients, as part of their culture, believe that a big

cut to the chest is extremely harmful and that patients who

have undergone CABG are too ill for society. The key point of

using PCI to manage CTO is having a good success rate.

g What are the disadvantages?

PCI of CTO is technically demanding and is associated with

greater radiation exposure than other PCI procedures. The

procedure is also more expensive, has an increased complication

rate, and has a steeper learning curve compared with PCI

procedures of simpler lesions. The operators experience

and choice of the various approaches to attempt the CTO

intervention is critical and heavily influence the outcome of the

procedure.

g What key factors should you consider when choosing a

device for PCI management of a CTO?

You should first and foremost consider the choice of guidewires.

Advances in coronary guidewire technology allow for more

agile crossing of CTO lesions. Wires have been specifically

designed to perform different functionsfor example,

hydrophilic, enhanced force and torque wires. The choice of

guidewire with its specific sensitivity is essential in determining

the correct placement of the wire in the true lumen or the

subintimal space. The support of the guidewire for other devices

needed also plays an important role in determining the success

of the CTO intervention. The emergence of new techniques and

technologies is revolutionising this field.

g Which access route would you usetransradial or

transfemoral?

Transradial PCI route is feasible for most CTO lesions. Compared

with transfemoral access, the transradial route has similar rates

of success and of major complications but is associated with

a lower minor complication rate. If back up support from the

guiding catheter is critical, the transfemoral approach using a

larger guiding catheter would be advantageous.

g What are your tips and techniques for performing PCI in

a patient with CTO?

Most of the CTO cases I have done in the last few years have

been with the antegrade approach. With this approach, I prefer

to use taped wires and slippery wires (such as Fielder XT and

Pilot 150) because of the microchannel concept. Normally, when

using antegrade approach, I use transradial access. In terms of

retrograde approach, I tend to use transfemoral access with

a 7F guiding catheter. The reverse controlled antegrade and

retrograde tracking (CART) technique has made a significant

contribution to improving the retrograde approach.

Performing high-quality PCI in a patient with a CTO is an

important concern and I do not think we should do too

extensive dissection,with either the antegrade or retrograde

approach, beyond the CTO body during PCI.

g What is the post PCI management of patients with CTOs?

Generally speaking, as CTO patients are usually implanted with

two or more stents, they will be at risk of restenosis as well as

stent thrombosis. Therefore, the duration of dual antiplatelet

therapy (DAPT) needs to be sufficient to reduce the risk of stent

thrombosis but at the same time, the increased risk of major

bleeding with prolonged DAPT should also be considered.

INTERVIEW

An interview with... Kam Tim Chan

The role of imaging and functional lesion assessment

Kam Tim ChanDivision of Cardiology, Queen Elizabeth Hospital, Hong Kong

Kam Tim Chan (Division of Cardiology, Queen Elizabeth

Hospital, Hong Kong) reviews the tools, such as functional

flow reserve (FFR), that are available for imaging and

functional assessment of coronary lesions prior to or post

percutaneous coronary intervention (PCI).

g What do we know about fractional flow reserve (FFR)?

FFR is a very useful modality to guide our management strategy,

especially in patients with multivessel disease and lesions of

intermediate severity. It provides an overall assessment of

the collateral circulation, which can indicate that anatomical

blockage in an artery functionally not actually significant. FFR

has been well validated in clinical trials (eg. DEFER, FAME I,

and FAME II) and international guidelines have given it a class

I indication.

g What are its disadvantages?

There is a limitation in applying FFR to the acute stage of

myocardial infarction or coronary syndromes, and also coronary

artery spasm, muscular bridging and microvascular diseases. To

get a good reading, FFR needs to be performed accuratelyfor

example, we give adenosine to achieve maximal hyperaemia

and this may cause conduction problems; bronchospasm and

hypotension. Therefore, caution is required in using FFR in

patients with heart block, asthma, haemodynamic instability, or

severe aortic stenosis. However, it is definitely a useful modality

to assess lesions of intermediate severity and lesions in which

the functional significance is in doubt.

g Could the use of instant wave free ratio (iFR) rather than

FFR overcome some of these issues?

Possibly, as iFR does not require maximal hyperaemia. At the

moment, our centre is collecting data to correlate FFR readings

with iFR readings, but we will definitely require more clinical

data for iFR before we can apply it in our daily clinical practices.

g What do we know about intravascular ultrasound (IVUS)?

Compared with an angiogram, IVUS can provide a much better

assessment of lesions characteristics and vessel size and is a

very useful tool for optimising post PCI results. But it is still

controversial whether the routine use of IVUS in conventional

lesions leads to improvement in clinical outcome after PCI as

there is still a lack of well validated evidence on this aspect.

I think that IVUS should be used for all PCI procedures (pre and

post) to the left main coronary artery as this is a very important

vessel. Also, IVUS can be used to clarify the condition and help

to plan the management strategy whenever ambiguity occurs

in angiogram, when there is haziness after stenting, or slow flow

or no reflow.


It incurs additional cost, you need expertise and training to

interpret the images, and there are reimbursement issues in

many countries. Also, you may not be able to see the stent

struts well owing to the lower resolution of IVUS.

g What do we know about optical coherence tomography

(OCT)?

In contrast to IVUS, OCT has higher resolution (10-15m) than

ultrasonography and you can see the intima and stent strut very

well. Therefore, it is good for assessing the stent strut coverage,

stent apposition, and for identifying the tiny dissection flaps or

thrombus owing to its excellent resolution. Also, it can be used

to assess thin cap atheroma.


There is a lack of long-term outcome data for the modality. Also,

you need to produce a bloodless field by flushing extra contrast

volume. Therefore, you have to be careful of using it in patients

with impaired renal function or heart failureparticularly in

patients with multivessel disease where multiple imaging is

needed.

g What other imaging modalities do you use at your centre

and why?

We use CT coronary angiogram and CT perfusion studies (under

clinical trial) and also regularly use MRI perfusion scanning as

it is non-invasive and can provide very useful information on

the anatomical and functional aspect of the lesions before

subjecting these patients to an invasive test.

g During imaging, what steps can you take to reduce the

risks from radiation to both the patient and the operator?

This is a very important issue to address in current day cardiac

interventional procedures. Better planning of the procedure

will reduce the total radiation exposure to patients. During

each procedure, we closely monitor the total radiation dose

for each patient to ensure that the exposure remains at safe

levels. Also, operators need to change their projection angles

regularly, particularly with complex PCI procedures such as

when managing chronic total occlusions. Operators need

to wear a radiation badge and have their radiation exposure

closely monitored, and they also need to undergo regular body

check-ups. In addition to radiation protection measures such

as lead aprons and shields, using a radiation protection pad,

following the radiation reduction protocol in many machines,

and decreasing the use of cine angiogram are ways of reducing

radiation dose to the operators.


Scientific programme

16th-18th January, 2014 - Singapore

15th January, 2014 - Practical PCI Pre-Course


SCIENTIFIC PROGRAMME

16

Programme at-a-glance

Interactive Case Corner Industry-supported sessionsPlenary session Educative sessions Training villageWith LIVEL

9 10 11 12 13 14 15 16 17 18 19 208:30 9:30 10:30 11:30 12:30 13:30 14:30 15:30 16:30 17:30 18:30 19:30

9 10 11 12 13 14 15 16 17 18 19 208:30 9:30 10:30 11:30 12:30 13:30 14:30 15:30 16:30 17:30 18:30 19:30

Brea

k

Lunch

Wednesday 15th January, 2014

Practical PCI roomPractical tips

in PCI techniques

Transradial & transfemoral

arterial access

Practical aspects of bifurcation

stenting

Left main stenting

Acute myocardial infarction

interventions

Techniques & devices

beyond stent implantation

Imaging & functional

lesion assessment

Practical implications

of latest trials

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system

and IVUS - iLAB imaging system

Innovation lab: learning with next generation devices and therapies

Clos

ing

Awar

ds

Brea

k

Brea

k

Brea

k

LIVE from

Thailand

LIVE from Singapore

LIVE from Thailand

Invasive imaging and physiology (IVUS/OCT/

FFR)- Part I

Interactive Case Corner X

Interactive Case Corner XI

Invasive imaging and physiology (IVUS/OCT/

FFR) - Part II

Interactive Case Corner XII

Lunch with Course Directors

TOPIC 5: TransradialNEW!L L L

Training Boston Scientific

Training Medtronic

Saturday 18th January, 2014

MAIN ARENA

ROOM 2

Interactive Case Corner

Focus on &

wrap-up

Brea

kBr

eak

Brea

kBr

eak

Brea

k

Brea

kBr

eak

Brea

kBr

eak

Brea

k

Focus on complications India, Indonesia & Viet Nam

Practical PCI tips & tricks

Forum: complications

Forum: TAVI

Interactive Case Corner V

Abstracts: structural

Interactive Case Corner VI

MitraClip LAALearning 2

stent bifurcation technique

My most educational case

Lunch

Lunch

Lunch

Lunch

Lunch

Lunch

TNT with LIVETerumo

SymposiumBiotronik

SymposiumOrbusNeich

Techniques & devices:

sympathetic nervoussystem for hypertension

control & LIVE from Singapore

Forum: PCI cases

Abstracts: imaging

Interactive Case Corner VIII

Interactive Case Corner VII

Learning transradial interventions

Haemodynamics support

Forum: complications

Interactive Case Corner IX

Nurses, technicians & radiographers - Part II

Brea

k

Brea

kLIVE from Singapore

LIVE from Singapore

LIVE from India

LIVE from Singapore

LIVE from India

LIVE from Singapore

Focus on &

Wrap-up

TOPIC 4: CTOTOPIC 3: Left Main & Multivessel

L L L L L

L

L

SFA & below the knee intervention

IVUS workshop

FFR workshop

OCT workshop

Chie

n Fo

unda

tion


and IVUS - iLAB imaging system

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system


Lunch

LunchInnovation lab: learning with next generation

devices and therapies

L

Friday 17th January, 2014

MAIN ARENA

ROOM 2

ROOM 3


ROOM 4

Peripheral room


Training Medtronic



and IVUS - iLAB imaging systemLunch

Lunch

Thursday 16th January, 2014

MAIN ARENA

ROOM 2

ROOM 3


ROOM 4

Peripheral room

Brea

kBr

eak

Brea

kBr

eak

Brea

kBr

eak

Focus on complications Hong Kong & Singapore

Abstracts: PCI in ACS

Interactive Case Corner I

Learning rotational atherectomy

Lunch

Lunch

Lunch

Lunch

Lunch

Lunch

TNT with recorded LIVEBoston Scientific

SymposiumAbbott Vascular

SymposiumMaquet Cardiovascular

SymposiumBiosensors International

SymposiumMedtronic & Terumo

Interactive practical session

on TAVI

TAVI with LIVE from

Singapore

Forum: PCI

complications

Abstracts: outcomes with

DES

Interactive Case Corner III

Interactive Case Corner II

Carotid & renal artery stenting

Learning transseptal PTMC

Congenital heart interventions

Forum: challenging issues with PCI

Interactive Case Corner IV

Nurses, technicians & radiographers - Part I

Forum

Welcome & LIVE from Singapore Fo

cus o

n

Open

ing

LIVE from Singapore

Focus on &

wrap-up

HSITBifurcation

LIVE from China

LIVE from China

Focus on &

Wrap-up

TOPIC 2: Bifurcation stenting (non left main)TOPIC 1: PCI using new technologies

L L L

L

L

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system


Training Medtronic


AsiaPCR/SingLIVE 2014 - Programme


17

PRACTICAL PCI ROOM

___ 09:30-17:50 ____________________________________

Attend this PCI Practical Pre-Course if you want:g To learn how to do basic PCIg To learn the different techniques to approach the cases

09:30-10:30 ____________________________ Plenary session

Practical tips in PCI techniquesChairpersons: E. Eeckhout, T.H. KohPanellists: A. Ong, D. Tresukosol, W. Wijns, A. Wong

g 10 mn Introduction - T.H. Koh g 10 mn Choice and manipulation of diagnostic and guiding

catheters - A. Ong g 10 mn Choice and manipulation of guide wires - D. Tresukosol g 10 mn Antiplatelet therapy - W. Wijns g 10 mn Management of uncommon situations - A. Wong g 10 mn Discussion & audience interaction

10:35-11:20 ____________________________ Plenary session

Transradial and transfemoral arterial accessChairpersons: B. Chevalier, J. TanPanellists: L. Bilodeau, T. Slagboom

g 5 mn Introduction - B. Chevalier g 10 mn Transradial interventions: how to deal with hostile

anatomy - T. Slagboom g 10 mn Management of vascular complications - J. Tan g 10 mn Transradial access (saphenous vein graft, Lima, Rima,

sheathless) - L. Bilodeau g 10 mn Discussion & audience interaction

11:25-12:20 ____________________________ Plenary session

Practical aspects of bifurcation stentingChairpersons: M.C. Morice, R. ZambahariPanellists: P. Chandra, N. Foin, B. Garcia Del Blanco, R.I. Low, W.A. Wan Azman

g 10 mn Technical considerations in bifurcation stentingBenchtop lessons - N. Foin

g 10 mn True bifurcation with only one stent - P. Chandra g 10 mn Culotte bifurcation stenting - B. Garcia Del Blanco g 10 mn T and TAP Stenting - M.C. Morice g 10 mn Crush/mini crush - W.A. Wan Azman g 5 mn Discussion & audience interaction

13:00-13:45 ____________________________ Plenary session

Left main stentingChairpersons: J. Fajadet, T. SantosoPanellists: C. Briguori, W. Kehasukcharoen

g 5 mn Introduction - J. Fajadet g 10 mn Imaging assisted left main stenting role of IVUS

W. Kehasukcharoen g 10 mn Ostial left main stenting and provisional T stenting

T. Santoso g 10 mn Distal bifurcation stenting (including simultaneous

kissing stent) - J. Fajadet g 10 mn Discussion & audience interaction

13:50-14:45 ____________________________ Plenary session

Acute myocardial infarction interventionsChairpersons: P. Chandra, A. WongPanellists: R. Bhindi, C. Briguori, M. DAmico, J.F. Iglesias, M. Noc

g 5 mn Introduction - A. Wong g 10 mn Use of new antiplatelet drugs and IIB-IIIA inhibitors

R. Bhindi g 10 mn How to perform thrombectomy and distal protection

J.F. Iglesias g 10 mn Managing cardiogenic shock in acute myocardial

infarction - M. Noc g 10 mn Complications management - M. Damico g 10 mn Discussion & audience interaction

14:50-15:40 ____________________________Plenary session

Techniques and devices beyond coronary stent implantationChairpersons: C.K. Naber, D. TresukosolPanellists: C. Briguori, I.H. Chae, N. Inoue, E. Merkulov, R. Zambahari

g 10 mn Drug-eluting balloons and cutting balloonsI.H. Chae

g 10 mn ABC of rotablation - R. Zambahari g 10 mn When the balloon does not cross the lesion

E. Merkulov g 10 mn When you cannot deliver the stent - N. Inoue g 10 mn Discussion & audience interaction

15:55-16:50 ____________________________ Plenary session

Imaging and functional lesion assessmentChairpersons: G. Guagliumi, S.T. LimPanellists: K.T. Chan, A. Low

g 5 mn Introduction - S.T. Lim g 10 mn ABC of FFR - A. Low g 10 mn 10 rules on radiation protection - S.T. Lim g 10 mn IVUS tips and tricks in interpretation - K.T. Chan g 10 mn ABC of OCT - G. Guagliumi g 10 mn Discussion & audience interaction

16:55-17:50 ____________________________ Plenary session

Practical implications of latest trialsChairpersons: M. Munawar, W. WijnsPanellists: S. Mishra, R.I. Low

g 3 mn Introduction - M. Munawar g 10 mn Acute coronary syndrome - R.I. Low g 10 mn Stent trials g 10 mn Multivessel and left main PCIs - M. Munawar g 10 mn Focus updates on new technologies drug-eluting

balloons, bioresorbable scaffolds - S. Mishra g 7 mn Discussion & audience interaction g 5 mn Wrap-up of the day - W. Wijns

End of the day

Wednesday 15th January, 2014

Programme



Programme

MAIN ARENA

___ 09:00-10:15 ____________________________________

Topic: PCI using new technologiesAttend these sessions if you want:g To learn about the advanced applications on bioresorbable

scaffoldsg To understand the value of intracoronary imaging in this

particular setting

09:00-10:00 _________________________ LIVE demonstration

Welcome and LIVE demonstration from the National Heart Centre SingaporeChairpersons: E. Eeckhout, T.H. KohPanellists: J.J. Cheng, J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. WijnsOperators: J. Fajadet, A. WongIVUS Moderator: J. HonyeWith continuous LIVE demonstration from the National Heart Centre Singapore

10:00-10:15 ________________________________Focus on

Focus on bioresorbable scaffoldsChairpersons: E. Eeckhout, T.H. KohPanellists: J.J. Cheng, J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. Wijns

g 15 mn Focus on bioresorbable scaffolds: the top 10 unanswered questions - P.W. Serruys

End of the topic

Opening session

___ 10:15-10:30 ___________________________ Plenary session

Welcome addressChairpersons: E. Eeckhout, T.H. KohPanellists: J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. Wijns

g 5 mn Opening ceremony - T.H. Kohg 5 mn Presentation of the Course and todays programme

E. Eeckhoutg 5 mn PCR Family - W. Wijns

___ 10:35-12:00 ____________________________________

Topic: PCI using new technologiesAttend these sessions if you want:g To learn about the new drug delivery stents g To learn how they can potentially reduce dual antiplatelet

therapy durationg To understand the value of intraconary imaging in this

particular setting


LIVE demonstration from the National Heart Centre SingaporeChairpersons: E. Eeckhout, T.H. KohPanellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan AzmanOperators: J.M. Fam, S.T. LimIVUS moderator: J. HonyeWith continuous LIVE demonstration from the National Heart Centre Singapore

11:35-11:55 ________________________________Focus on

Focus on dual antiplatelet therapy durationChairpersons: E. Eeckhout, T.H. KohPanellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan Azman

g 15 mn Shortening dual antiplatelet therapy durationH.C. Gwon

g 5 mn Global leaders trial presentation - P.W. Serruys

11:55-12:00 ____________________________ Plenary session

Wrap-upChairpersons: E. Eeckhout, T.H. KohPanellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan Azmann

g 5 mn Wrap-up by Damras Tresukosol

End of the topic


Programme



19

___ 16:15-17:55 ____________________________________

Topic: Bifurcation stenting (non left main)Attend these sessions if you want:g To understand indication and techniques in the treatment

of ostial side branch lesion


LIVE demonstration from Xijing Hospital, Xi-an, ChinaChairpersons: J. Fajadet, S.T. LimPanellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. SuryapranataOperator: W.Y. Guo

With continuous LIVE demonstration from Xijing Hospital, Xi-an, China

17:15-17:50 _______________________________ Focus on

Focus on bifurcationChairpersons: J. Fajadet, S.T. LimPanellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. Suryapranata

g 10 mn Bifurcation stenting techniques using bioresorbable scaffolds - A. Seth

g 10 mn When to consider using dedicated bifurcation stentsB. Chevalier

g 15 mn My 10 keypoints about bifurcation stentingM.C. Morice

17:50-17:55 ____________________________Plenary session

Wrap upChairpersons: J. Fajadet, S.T. LimPanellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. Suryapranata

g 5 mn Wrap-up by Jean Fajadet

End of the topic

___ 18:00-19:20 ______________________________ Symposium

New concepts for improved patient outcomesWith an unrestricted educational grant from Biosensors InternationalChairpersons: T.H. Koh, K.G. OldroydPanellists: B. Garcia Del Blanco, F.Y. Kuo, J. Tan

Attend this session if you want: g To learn about the new concepts in treating patients for better clinical outcomes g To understand clinical benefits to use biodegradable polymer DES in acute myocardial infarction patients g To gain insights on dual antiplatelet therapy early discontinuation

g 5 mn Introduction and objectives - T.H. Koh g 15 mn Changing practice: is it safe to use biodegradable

polymer DES in acute myocardial infarction? - F.Y. Kuo g 15 mn Long-term outcomes with BioLimus from BEACON II

Asia Population - T.H. Koh g 15 mn Raising the standard in treating bifurcation lesions

B. Garcia Del Blanco g 15 mn Patients with high bleeding risk: which stent, which

dual antiplatelet therapy regimen - K.G. Oldroyd g 10 mn Discussion & audience interaction g 5 mn Take-home message - K.G. Oldroyd

Thursday 16th January, 2014 - Main Arena

___ 12:35-13:55 ______________________ Tools & Techniques (TNT)

Advancing cardiology together with innovative technologies and meaning clinical researchWith an unrestricted educational grant from Boston ScientificChairpersons: J. Fajadet, T.H. KohPanellists: D.C.Y. Cheung, C.T. Chin, L. Kalidoss, A. Menon, M.C. Morice, A. Ong, F. Posas, T. SelvanAttend this session if you want: gTo learn how polymers and stent materials impact healing g To demonstrate the Vessix multi-point system features and its anatomical and clinical use gTo introduce Lotus: safety and performances

g 2 mn Introduction and objectives - T.H. Koh g 10 mn Clinical evidences in catheter-based renal sympathetic

denervation: building the data - F. Mahfoud g 30 mn Recorded LIVE demonstration: vessix - C.T. Chin g 5 mn Discussion & audience interaction g 15 mn Unique abluminal bioabsorbable polymer and

a unique customised architecture - H.C. Tan g 5 mn Discussion & audience interaction g 10 mn TAVR LOTUS Valve - E. Grube g 3 mn Take-home message - J. Fajadet

___ 14:00-16:00 ____________________________________

Topic: Bifurcation stenting (non left main)Attend these sessions if you want:g To learn the different 2 stent techniques for complex

bifurcationg To learn about the value of functional and morphological

assessment during intervention in this setting


LIVE demonstration from Xijing Hospital, Xi-an, ChinaChairpersons: R. Ng, W. WijnsPanellists: I.H. Chae, M.S. Kalarickal, P.W. Serruys, J. Tan, E. Tsuchikane, C.J. Wu, F. Yoshimachi, R. ZambahariOperator: W.Y. Guo

With continuous LIVE demonstration from Xijing Hospital, Xi-an, China

15:00-16:00 ____________________ How should I treat? session

How should I treat bifurcation?Chairpersons: R. Ng, W. WijnsPanellists: I.H. Chae, M.S. Kalarickal, P.W. Serruys, J. Tan, E. Tsuchikane, C.J. Wu, F. Yoshimachi, R. Zambahari g 5 mn Case presentation - S.L. Chen g 5 mn How would I treat? - H.H. Ho g 5 mn How would I treat? - A. Seth g 10 mn How did I treat? - S.L. Chen g 5 mn Discussion and audience interaction g 5 mn Case presentation - D. Tresukosol g 5 mn How would I treat? - W. Wijns g 5 mn How would I treat? - T. Santoso g 10 mn How did I treat? - D. Tresukosol g 5 mn Discussion and audience interaction

End of the topic



Programme

ROOM 2

___ 10:30-12:00 ____________________________ Plenary session

Focus on stent related complications: Hong Kong and SingaporeWith the collaboration of the Hong Kong College of Cardiology and the National Heart Centre SingaporeChairpersons: K.T. Chan, P. WongPanellists: W.H.N.S.C. Chan, J. Berland, G.H. Choo, M. Yamin, C.K.Y. Wong

Attend this session if you want: gTo learn how to manage coronary complications

g 12 mn In-stent restenosis coronary chronic total occlusion: same subintimal tracking and re-entry (STAR) or different beast - L. Ho

g 3 mn Discussion & audience interaction g 12 mn Case presentation - H.K. Woon g 3 mn Discussion & audience interaction g 12 mn The only 1,5% - E. Wong g 3 mn Discussion & audience interaction g 12 mn Left main stent compression - an oops! moment

J.H. Jafary g 3 mn Discussion & audience interaction g 12 mn A case of unprotected left main intervention

complicating acute stent thrombosis - G. Cheung g 3 mn Discussion & audience interaction g 12 mn What matters in thrombosis? - R.C.H. Lee g 3 mn Discussion & audience interaction

___ 12:35-13:55 ______________________________ Symposium

Polymer DES safety and BVS case sharingWith an unrestricted educational grant from Abbott VascularChairperson: R. NgPanellists: S.T. Lim, A. Low, D.N. Muda, J. Tan, R.J. Van Geuns

Attend this session if you want: g To understand biodegradable polymer does not contribute extra benefit in DES g To share BVS Performance in acute myocardial infarction and bifurcation

g 5 mn Introduction and objectives - S.T Lim g 20 mn Biodegradable polymer offers no extra benefit in DES

J. Tan g 20 mn BVS case based discussion in acute myocardial

infarction - A. Low g 20 mn BVS case based discussion in bifurcation - RJ. Van Geuns g 10 mn Discussion & audience interaction g 5 mn Take-home message - R. Ng

___ 14:00-16:00 ___________________________ Plenary session

Sessions on TAVIAttend these sessions if you want:g To understand what TAVI can offer to your patients, with

CoreValve & Sapien deviceg To raise knowledge on how to successfully perfom TAVI

procedure with CoreValve & Sapien device


LIVE demonstration from the National Heart Centre SingaporeChairpersons: R.M. Ali, M. ThomasPanellists: S. Cook, E. Grube, K. Hayashida, F. Posas, S. Redwood, Y.K.K. Sin, D. TchtchOperators: P. Chiam, K.W. Ho3D TEE moderator: S.H. EweSurgical expert: J.L. Soon

With continuous LIVE demonstration from the National Heart Centre Singapore

15:00-16:00 ___________________________ Plenary session

Case-based interactive discussion on TAVIFacilitators: R.M. Ali, S. RedwoodPanellists: S. Cook, E. Grube, K. Hayashida, F. Posas, Y.K.K. Sin, D. Tchtch, M. Thomas

With recorded LIVE demonstration

___ 16:15-17:55 ____________________________ Plenary session

Congenital heart interventionsChairpersons: E. Eeckhout, J.L. TanPanellists: M. Alwi, S. Chandra, P.C. Mondal, M.H. Pham, S. Radhakrishnan, J. Yip

Attend this session if you want: g To learn about contemporary treatment of common congenital heart disease

g 5 mn Introduction - J.L. Tan g 15 mn Practical approach to closing large and complex atrial

septal defects - S. Radhakrishnan g 3 mn Discussion & audience interaction g 8 mn Successful percutaneous device closure for giant atrial

septal defect with massive pericardial effusion and pulmonary hypertension in an elderly patientT. Sakamoto

g 4 mn Discussion & audience interaction g 15 mn CoA stenting: what is known and what is new

M.H. Pham g 3 mn Discussion & audience interaction g 8 mn Plug the arteriovenous malformation (AVM) - V. Kumar g 4 mn Discussion & audience interaction g 15 mn Practical tips for successful pulmonary valvuloplasty

and stenting arteries - M. Alwi g 3 mn Discussion & audience interaction g 8 mn A case of chronic thromboembolic pulmonary

hypertension disengaged from oxygen therapy after balloon pulmonary angioplasty - R. Fukuoka

g 4 mn Discussion & audience interaction g 5 mn Consensus - E. Eeckhout




21

___ 18:00-19:20 ______________________________ Symposium

Shared symposium on catheter-based renal sympathetic denervationWith an unrestricted educational grant from Medtronic and Terumo

Part I: Leading the way in the renal denervation: the Symplicity innovation programmeChairperson: F. MahfoudPanellists: S.T. Lim, J.K.B. Tan, T.W. LimAttend this session if you want: g To learn about clinical data from Symplicity HTN-1, HTN-2, and Global Symplicity Registry in Asia Pacific gTo learn about the First in Man experience with gSymplicity Spyral and the Symplicity Design Story g To learn about Symplicity HTN-3 and HTN-4 trial design and interpreting ABPM vs OBPM results

g 3 mn Introduction & objectives - F. Mahfoud g 10 mn How far have we come? Symplicity HTN-1,-2, Global

Symplicity registry - S.T. Lim g 10 mn Where are we now? Spryral, design story - J.K.B. Tan g 10 mn How far can we go? ABPM vs OBP, Symplicity HTN-3,-4,

HF - T.W. Lim g 5 mn Discussion & audience interaction g 2 mn Take-home message - F. Mahfoud

Part II: Towards better patients care: optimising renal sympathetic denervationChairpersons: F. Mahfoud, T. SantosoPanellists: T. Benjanuwattra, H.H. HoAttend this session if you want: g To learn about current renal sympathetic denervation and future potential g To discuss about less invasive renal nerve ablation procedure from radial artery; its benefits and challenges g To learn about experience of Iberis Renal Sympathetic Denervation Systems

g 5 mn Introduction and objectives - T. Santoso g 10 mn Renal sympathetic denervation: current and future

F. Mahfoud g 10 mn Renal denervation and its potential benefit and

challenge of transracial approach - H.H. Ho g 10 mn Case presentation - T. Benjanuwattra g 5 mn Take-home message - F. Mahfoud

ROOM 3

___ 10:30-12:00 ____________________________ Abstract session

Abstracts: PCI in Acute coronary syndromeSession comprising selected AsiaPCR/SingLIVE 2014 abstracts submissions Chairpersons: Y.T. Lim, O. VarennePanellists: T. Slagboom, C.H. Tan, P. Tedjokusumo

g 8 mn Comparable low rates of major adverse cardiovascular events in patients with ST-elelvation and non ST-elevation acute coronary syndromes treated with biolimus eluting stents in the 12-month follow-up of the all-comers e-BioMatrix registry - K.G. Oldroyd

g 4 mn Discussion & audience interaction g 8 mn Efficacy of Lacrosse NSE balloon using the Leopard-

Crawl technique on severely calcified lesionsK. Ashida

g 5 mn Discussion & audience interaction g 8 mn Procedural implications of persistent right innominate

artery tortuosity (tapan sign) during right transradial or trans ulnar coronary intervention: a prospective case controlled multicentre study - T. Ghose

g 5 mn Discussion & audience interaction g 8 mn Impact of endothelial progenitor cell capturing stent

on coronary microvascular function: comparison with drug eluting stent - S.H. Kim

g 5 mn Discussion & audience interaction g 8 mn 5 years clinical follow up results of endothelial cell

capturing stents in acute coronary syndrome in Indian patients - T. Ghose

g 5 mn Discussion & audience interaction g 8 mn Impact of final kissing balloon inflation after simple

stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome - T.H. Kim

g 5 mn Discussion & audience interaction g 8 mn TIMI myocardial perfusion grade (TMPG) and

myocardial viability (MV) assessment using dobutamine stress echocardiogram in patients post acute coronary syndromes - J.R. Ismail

g 5 mn Discussion & audience interaction

Thursday 16th January, 2014 - Room 2



Programme

___ 12:35-13:55 ______________________________ Symposium

Tailoring haemodynamic support to the specific needs of the unstable patient undergoing PCIWith an unrestricted educational grant from Maquet CardiovascularChairpersons: S. Redwood, A. WongPanellists: P. Chandra, P.J.L. Ong, M. Thomas, S. Rathnavel

Attend this session if you want: g To discuss the haemodynamics of mechanical circulatory support in the unstable patient undergoing PCI g To understand the indications for percutaneous extra-corporeal membrane oxygenation (ECMO) vs. percutaneous ventricular assist or intra-aortic balloon pump therapy g To discuss real world experience and outcomes in treating complex PCI procedures

g 5 mn Introduction and objectives - A. Wong g 10 mn Case presentation: percutaneous extra-corporeal

membrane oxygenation vs. percutaneous ventricular assist or intra-aortic balloon pump therapy: which device and when? - P. Chandra

g 10 mn How would I treat? Expert opinion - P.J.L. Ong g 10 mn How would I treat? Expert opinion - M. Thomas g 5 mn How did I treat? - P. Chandra g 10 mn Case presentation: IABP SHOCK II Trial: what does

this mean for your clinical practice? - S. Rathnavel g 10 mn How would I treat? Expert opinion - P.J.L. Ong g 10 mn How would I treat? Expert opinion - M. Thomas g 5 mn How did I treat? - S. Rathnavel g 5 mn Take-home message - S. Redwood

___ 14:00-15:00 ____________________________ Abstract session

Abstracts: outcomes with drug eluting stentSession comprising selected AsiaPCR/SingLIVE 2014 abstracts submissionsChairpersons: S. Hardt, K.H. SimPanellists: B.B. Darmadjati, A. Rahman, R.J. Van Geuns, Y.H. Oktaviono

g 8 mn Four year clinical outcomes and predictors of coronary revascularisation among patients treated with newer-generation drug-eluting stents - M. Taniwaki

g 4 mn Discussion & audience interaction g 8 mn Very long time follow-up after percutaneous closure

of patent foramen ovale - E. Eeckhout g 4 mn Discussion & audience interaction g 8 mn Very long-term safety and efficacy outcomes of all

comers BEACON II registry: five year follow-up and final report of the study - T.H. Koh

g 4 mn Discussion & audience interaction g 8 mn Does the existence of primer coating on biolimus-

eluting stents with abluminal biodegradable polymer influence clinical outcomes? Insights from the large all-comers eBioMatrix registry - I. Menown

g 4 mn Discussion & audience interaction g 8 mn Decreasing importance of distance from home to

the nearest invasive centre for performing diagnostic coronary angiography among patients with acute coronary syndromes: a national study - S. Galatius


15:05-16:00 ____________________________________ Forum

Forum: PCI ComplicationsSession comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: F. Mahfoud, S.C. NgPanellists: T. Benjanuwattra, C.Y. Chou, B. Zhang

g 8 mn A case of successful bailing out from severe longitudinal deformation due to an inner catheter after postdilation with a large-caliber balloon - Y. Seiji

g 4 mn Discussion & au dience interaction g 8 mn Diffuse calcified lesion: a sticky encounter - S. Khan g 4 mn Discussion & audience interaction g 8 mn Catheter-induced dissection at ostium of right

coronary artery with abnormal origin - N.Q. Nguyen g 4 mn Discussion & audience interaction g 8 mn Why knot? - V. Mironov g 4 mn Discussion & audience interaction

___ 16:15-17:45 _________________________________ Forum

Forum: challenging issues in PCISession comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: P.W. Serruys, P. YanPanellists: M. Chan, A.A. Lukito, Q.T. Nguyen, T.P. Tsao

g 8 mn Acute anterior STEMI immediately post CABG: how to manage? - K. Fouad

g 4 mn Discussion & audience interaction g 9 mn STEMI in a young lady with deficient protein S

H. Shaalan g 4 mn Discussion & audience interaction g 9 mn Acute ST-elevation myocardial infarction triggered by

drinking bhang (cannabis) - D. Natarajan g 4 mn Discussion & audience interaction g 9 mn When the itching hurts - M. Cardenas Manilla g 4 mn Discussion & audience interaction g 9 mn An unusual case of new coronary lesion of left main

and just proxysmal left anterior descending artery after Bentall operation successfully treated with percutaneous - H. Tsuneoka

g 4 mn Discussion & audience interaction g 9 mn Stent graft failure eight years post insertion in a left

internal mammary artery (LIMA) graft to close a missed side branch - N. Okasha

g 4 mn Discussion & audience interaction g 9 mn PCI in dextrocardia situs inversus and severe

hypothyroidism - D. Natarajan g 4 mn Discussion & audience interaction

Thursday 16th January, 2014 - Room 3



23

ROOM 4

___ 10:30-12:00 _____________________________________

Learning rotational atherectomyFacilitators: T. Cuisset, J. Tan, D. TchtchResource experts: M.S. Kalarickal, R.I. LowMedia driver: D. YongAttend this session if you want:g To review the basic principles, patient and lesion selection

for rotational atherectomyg To understand how to safely and successfully perform a

rotational atherectomyg To find out how to solve the most frequent issues

___ 14:00-16:00 _____________________________________

Learning transseptal and percutaneous transseptal mitral commissurotomyFacilitators: S. Khan, K.K. YeoResource expert: M.H. PhamMedia driver: K.L. LeowAttend this session if you want:g To learn the techniques of transseptal puncture and

percutaneous transseptal mitral commissurotomyg To review the indications and evidence of percutaneous

transseptal mitral commissurotomyg To understand and manage complications

___ 16:15-17:50 _____________________________________

Nurses, technicians and radiographers - Part IAssisting for FFR measurements in the cathlabFacilitators: S. Buendia, C.T. Chin, V. KwokResource expert: K.T. ChanAttend this session if you want: g To understand the key roles of cathlab professionals

and team work in performing FFR measurements with a pressure wire

INTERACTIVE CASE CORNER

___ 10:30-12:00 _____________________________________

Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: R.K. Abhaichand, B. Chevalier

gSame costume, different character - M. Cardenas Manilla gPrice of missing ostium - R. Chawla g The curious case of the intermittently open and close vesselC.T. Chin g ACS and severily calcified left main disease: how should I treat? - V. Mironov g Severely calcified left main bifurcated lesion treated with rotational atherectomy and culottes stenting - H. Nishina gPCI in single coronary artery: a challenging case - S. Khanal g Complicated primary PCI: what is wrong with our approach?L.H. Dinh

___ 14:00-14:40 _____________________________________

Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: J. Fajadet, G. Sengottuvelu

g Very late stent thrombosis (VLST) occurring five years after deployment of second generation drug-eluting stent treated by bioresorbable scaffolds during transradial direct primary angioplasty without prior knowledge of right coronary artery anatomy - T. Ghose g A case of retrograde PCI for left circumflex coronary chronic total occlusion from ipsilateral channel: how to get skill of retrograde approach - M. Yoshida g Nightmares in Cathlab Title: what did happen at the end of PCI and stenting? - S.M. Hossain g Simultaneous coronary and valvular intervention - M. Srinivas

___ 14:45-16:00 _____________________________________

Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: J.B. Ge, M.C. Morice

g Coronary AV fistula closure during primary PCI for inferior STEMI - N. Okasha g Retrograde chronic coronary total occlusion intervention via ipsilateral collaterals - S. Victor g Where we went wrong: mortality - R. Chawla g Coronary aneurysm after DES implantation in a psoriatic patient - L.P. Suciadi g Preventive PCI in bifurcated left main disease in the setting of primary PCI where the culprit vessel is the right coronary artery - H. Rahman g Microcatheter support good way to deliver stentsG. Sengottuvelu

___ 16:15-17:30 _____________________________________

Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: N. Chouhan, W.A. Wan Azman, W. Wijns

g OCT guided PCI with single stenting of left main coronary artery to left circumflex to obtuse marginal (OM) branchK. Sridhar g Left main stenosis and infarct-related left anterior descending artery: single-stage or sequent PCI? - E. Merkulov g Use of bioresorbable scaffolds during transradial primary angioplasty - T. Ghose g Successful angioplasty of right coronary artery coronary chronic total occlusion and left main bifurcation lesionsC.C. Chang g What happened to this young lady with acute myocardial infarction? - J.M. Fam




Programme

PERIPHERAL PROGRAMME

3rd FLOOR

___ 14:00-16:00 ____________________________ Plenary session

Carotid and renal artery stenting and Takayasu arteritis interventionChairpersons: S.W. Rha, M. TanejaPanellists: C.I. Cheng, B. Chua

g 2 mn Introduction and objectives - S.W. Rha g 10 mn Catheters, guidewires and embolic protection devices

for carotid angioplasty: what is new in 2014? - S.W. Rha g 10 mn 2014 update on carotid artery stenting versus carotid

endarterectomy: does carotid artery disease still have a future? - N. Khanna

g 10 mn My top tips and tricks for carotid artery stentingS.W. Rha

g 12 mn A case of carotid artery stenting that I regret doingM. Taneja

g 10 mn Debate: after CORAL, ASTRAL and STAR trials, is there still a role for renal artery stenting? definitely - S.T. Lim

g 10 mn Debate: after CORAL, ASTRAL and STAR trials, is there still a role for renal artery stenting? no way - C.M. Chan

g 8 mn An educational case of renal artery stenting - K. Sridhar g 4 mn Discussion & audience interaction g 10 mn My top dos and donts for renal artery stenting

S.W. Rha g 12 mn Takayasus arteritis: endovascular treatment tips and

tricks - N. Khanna g 8 mn A memorable case of Takayasu arteritis intervention

K. Sridhar g 14 mn Discussion & audience interaction

___ 16:15-17:30 _________________________________ Forum

Peripheral case forumChairpersons: N. Khanna, K.K. YeoPanellists: B. Chua, F.Y. Kuo, F. Posas, S.W. Rha, J. Tan, D. Tresukosol

g 3 mn Introduction and objectives - N. Khanna g 8 mn Successful treatment of acute femoral artery

occlusion by percutaneous Fogarty balloon catheter embolectomy - Y. Takahashi

g 4 mn Discussion & audience interaction g 8 mn A case of endovascular fenestration for aortic

dissection Stanford type B with acute malperfusionM. Sato

g 4 mn Discussion & audience interaction g 8 mn Interventional closure of pseudo aneurysm developed

following Percutaneous transluminal angioplasty with stenting of abdominal aorta - A.K. Mahapatro

g 4 mn Discussion & audience interaction g 8 mn Useful three-dimensional information provided by

angioscopy during lower limb intervention: a case report - N. Takafumi

g 4 mn Discussion & audience interaction g 8 mn In stent occlusive lesion treated by eccentric method,

direct superficial femoral artery stent punctureT. Haraguchi



TRAINING WORKSHOPS

BOSTON SCIENTIFIC TRAINING ROOM

___ 09:00-12:00 ________________________________________ 13:00-17:00 _____________________________________

Interactive workshop: rotablator atherectomy system, Vessix renal denervation system and IVUS - iLAB imaging systemWith an unrestricted educational grant from Boston Scientific

Attend this session if you want:g To have hands-on training on the use of Rotablator in wet-

heart model g To have hands-on training on the use of Vessix Renal

Denervation System g To have hands-on training on the use of iLAB imaging System

g Rotablator atherectomy system: pre-treating calcified lesions with rotational atherectomy can be one of the best way to enhance proper stent placement. The

AsiaPCR2014 Programme Final

Documents

practical pci course

course directors

dynamic worldclass course

years programme

programme committee

new aspects

practical information

pcr community